학술논문

Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study’s analysis of heavily pretreated patients
Document Type
Article
Source
In: Therapeutic Advances in Urology. (Therapeutic Advances in Urology, January-December 2024, 16)
Subject
Language
English
ISSN
17562880
17562872